Amy Maxmen reports on how experimental peptides are being hyped in optimization circles and where the talk goes wrong.
Recap by typeshit. Post by Facebook on Facebook.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.
Gannan Medical University researchers screened 6,000 candidates from Hypsizygus marmoreus and found peptides that may help cut sodium without losing flavor.
8:28
A weight loss doctor walks through retatrutide, which she calls the most anticipated obesity drug currently in clinical trials.
Loading…